| Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma G Roex, M Timmers, K Wouters, D Campillo-Davo, D Flumens, ... Journal of hematology & oncology 13, 1-14, 2020 | 157 | 2020 |
| Chimeric antigen receptor-modified T cell therapy in multiple myeloma: beyond B cell maturation antigen M Timmers, G Roex, Y Wang, D Campillo-Davo, VFI Van Tendeloo, Y Chu, ... Frontiers in immunology 10, 1613, 2019 | 95 | 2019 |
| Dendritic cell-based immunotherapy of acute myeloid leukemia HH Van Acker, M Versteven, FS Lichtenegger, G Roex, D Campillo-Davo, ... Journal of clinical medicine 8 (5), 579, 2019 | 76 | 2019 |
| Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data G Roex, T Feys, Y Beguin, T Kerre, X Poiré, P Lewalle Pharmaceutics, 2020 | 67* | 2020 |
| Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells G Roex, D Campillo-Davo, D Flumens, PAG Shaw, L Krekelbergh, ... Journal of translational medicine 20 (1), 124, 2022 | 44 | 2022 |
| The ins and outs of messenger RNA electroporation for physical gene delivery in immune cell-based therapy D Campillo-Davo, M De Laere, G Roex, M Versteven, D Flumens, ... Pharmaceutics 13 (3), 396, 2021 | 35 | 2021 |
| The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy HH Van Acker, D Campillo-Davo, G Roex, M Versteven, EL Smits, ... Cytokine & growth factor reviews 41, 54-64, 2018 | 31 | 2018 |
| Rapid assessment of functional avidity of tumor-specific T cell receptors using an antigen-presenting tumor cell line electroporated with full-length tumor antigen mRNA D Campillo-Davo, M Versteven, G Roex, H De Reu, S van der Heijden, ... Cancers 12 (2), 256, 2020 | 19 | 2020 |
| IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts A Van den Eynde, L Gehrcken, T Verhezen, HW Lau, C Hermans, ... Journal of Hematology & Oncology 17 (1), 8, 2024 | 14 | 2024 |
| Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor Y Wang, Y Gao, C Niu, B Wang, S Zhao, G Roex, J Qian, J Qie, L Chen, ... Cancer Immunology, Immunotherapy 71 (11), 2801-2814, 2022 | 7 | 2022 |
| Chimeric antigen receptor-modified T cell therapy in multiple myeloma: beyond B cell maturation antigen. Front Immunol. 2019; 10: 1613 M Timmers, G Roex, Y Wang, D Campillo-Davo, VFI Van Tendeloo, Y Chu, ... Epub 2019/08/06. doi: 10.3389/fimmu. 2019.01613. PubMed PMID: 31379824, 2019 | 5 | 2019 |
| One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation D Flumens, D Campillo-Davo, I Janssens, G Roex, J De Waele, ... STAR protocols 4 (1), 102112, 2023 | 2 | 2023 |
| Designing and combining chimeric antigen receptors for improved cellular immunotherapy of hematological malignancies G Roex University of Antwerp, 2024 | | 2024 |
| Harnessing the Full Potential of Regulatory T Cells by mRNA-induced Antigen Specificity DW Scott, I Janssens, M Van Delen, D Flumens, A Dams, G Roex, ... The Journal of Immunology 210 (1_Supplement), 85.11-85.11, 2023 | | 2023 |
| HARNESSING CD70-DIRECTED CAR NATURAL KILLER CELLS WITH IL-15 IS NECESSARY TO ERADICATE SOLID TUMOUR CELLS AND CANCER-ASSOCIATED FIBROBLASTS A Van Den Eynde, J Van Audenaerde, J De Waele, T Flieswasser, ... HUMAN GENE THERAPY 33 (7-8), A21-A21, 2022 | | 2022 |
| DEVELOPMENT OF AN OFF-THE-SHELF BCMA/CD19 CAR-NK CELL THERAPY FOR B CELL MALIGNANCIES G Roex, D Campillo-Davo, H De Reu, Z Berneman, E Lion, S Anguille HUMAN GENE THERAPY 33 (7-8), A29-A30, 2022 | | 2022 |
| Chimeric antigen receptor T-cells: a new therapeutic option for relapsed/refractory B-cell malignancies and beyond T Feyx, G Roex, Y Beguin, T Kerre, X Poiré, P Lewalle, P Vandenberghe, ... Belgian Journal of Hematology 10, 2019 | | 2019 |
| GENERATION OF WILMS'TUMOR 1 TCR-REDIRECTED CD4 AND GAMMA-DELTA T CELLS BY RNA ELECTROPORATION AND CO-TRANSFER OF CD8 MRNA D Campillo, G Roex, HH Van Acker, ZN Berneman, E Lion, ... Human Gene Therapy 29 (11), A8-A9, 2018 | | 2018 |
| Ontwikkeling van humane T cellen met gemodificeerde T-celreceptor en karakterisering van hun antitumoractiviteit G Roex KU Leuven, 2018 | | 2018 |
| Generation of T cell receptor-redirected human T cells and the characterisation of their anti-tumour activity G Roex KU Leuven, 2018 | | 2018 |
Viggo Van TendelooUniversity of Antwerp在 uza.be 的电子邮件经过验证
